You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PANHEPRIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Panheprin patents expire, and what generic alternatives are available?

Panheprin is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in PANHEPRIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Panheprin

A generic version of PANHEPRIN was approved as heparin sodium by HOSPIRA on April 28th, 1983.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PANHEPRIN?
  • What are the global sales for PANHEPRIN?
  • What is Average Wholesale Price for PANHEPRIN?
Summary for PANHEPRIN
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:PANHEPRIN at DailyMed
Drug patent expirations by year for PANHEPRIN

US Patents and Regulatory Information for PANHEPRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira PANHEPRIN heparin sodium INJECTABLE;INJECTION 005264-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PANHEPRIN heparin sodium INJECTABLE;INJECTION 005264-008 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PANHEPRIN heparin sodium INJECTABLE;INJECTION 005264-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PANHEPRIN heparin sodium INJECTABLE;INJECTION 005264-007 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PANHEPRIN heparin sodium INJECTABLE;INJECTION 005264-009 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.